Correlation Between the Clinical Parameters and Tissue Phenotype in Patients Affected by Deep-Infiltrating Endometriosis

The current study aimed to identify and validate an applicable immunohistochemistrypanelincluding Ki-67, c-MYC, estrogen receptor-α (ER-α), and progesterone receptor isoforms A/B (PR-A/B) in correlation with clinicopathological parameters in patients affected by deep infiltrating endometriosis. Tissue microarrays were prepared from a cohort of I 13 patients. Phenotypic profile of the panel molecules was evaluated in glands and stroma in parallel with microvessels and stroma density measurements. Principal component analysis was performed on 8 immunohistochemical variables, 2 histological variables, and 8 subgroups of clinical parameters. The immunohistochemical profiling showed consistent Ki-67 immunostaining in 17.9% of the samples and c-MYC in 83.1%, while intense ER-a immunoreactivity was detected in 84% of the samples and PR-A/B isoforms in 24.1% of them. The combination of clinical parameters and tissue phenotype allowed a stratification of endometriosis-affected patients. Such novel phenotypical and clinical correlation could be helpful in the future studies for a better stratification of the disease aiming at a personalized patient care. Similar content being viewed by others

Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–279. Koninckx PR. Biases in the endometriosis literature. Illustrated by 20 years of endometriosis research in Leuven. Eur J Obstet Gyne-col Reprod Biol. 1998;81(2):259–271. Koninckx PR, Ussia A, Adamyan L, Wattiez A, Donnez J. Deep endometriosis:definition, diagnosis, and treatment. Fertil Steril. 2012;98(3):564–571. Brouwer R, Woods RJ. Rectal endometriosis:results of radical excision and review of published work. ANZ J Surg. 2007;77(7):562–571. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril. 1998;69(6):1042–1047. Li SF, Nakayama K, Masuzawa H, Fujii S. The number of pro-liferating cell nuclear antigen positive cells in endometriotic lesions differs from that in the endometrium. Analysis of PCNA positive cells during the menstrual cycle and in post-meno-pause. Virchows Arch A Pathol Anat Histopathol. 1993; 423(4):257–263. Meresman GF, Auge L, Baranao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril. 2002;77(6):1141–1147. Calcagno A, Grassi T, Mariuzzi L, et al.. Expression patterns of Aurora A and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model. Hum Reprod. 2011;26(10):2731–2741. Hapangama DK, Turner MA, Drury JA, et al.. Sustained replication in endometrium of women with endometriosis occurs without evoking a DNA damage response. Hum Reprod. 2009;24(3):687–696. Fujimoto J, Hori M, Ichigo S, Nishigaki M, Tamaya T. Tissue differences in the expression of mRNAs of Ha-ras, c-myc, fos and jun in human uterine endometrium, myometrium and leiomyoma underthe influence of estrogen/progesterone. Tumour Biol. 1994; 15(6):311–317. Alcazar JL, Garcia-Manero M. Ovarian endometrioma vascularization in women with pelvic pain. Fertil Steril. 2007;87(6):1271–1276. Zhao Y, Gong P, Chen Y, et al.. Dual suppression of estrogenic and inflammatory activities for targeting of endometriosis. Sci Transl Med. 2015;7(274):274erl. Huhtinen K, Desai R, Stahle M, et al.. Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. J Clin Endocrinol Metab. 2012;97(11):4228–4235. Borghese B, Mondon F, Noel JC, et al.. Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol. 2008; 22(11):2557–2562. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab. 2000;85(8):2897–2902. Revised American Society for Reproductive Medicine Classification of Endometriosis: 1996. Fertil Steril. 1997;67(5):817–821. Hoos A, Urist MJ, Stojadinovic A, et al.. Validation of tissue microarrays for immunohistochemical profiling of Cancer speci-mens using the example of human fibroblastic tumors. Am J Pathol. 2001;158(4):1245–1251. Kononen J, Bubendorf L, Kallioniemi A, et al.. Tissue microarrays for high-throughput molecular profiling of rumor speeimens. Nat Med. 1998;4(7):844–847. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogen-esis and metastasis-correlation in invasive breast Carcinoma. NEngl J Med. 1991;324(1):1–8. Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histolo-gical categorisation of fibrotic Cancer stroma in advanced rectal Cancer. Gut. 2004;53(4):581–586. Chapron C, Souza C, Borghese B, et al.. Oral contraceptives and endometriosis:the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod. 2011; 26(8):2028–2035. Peveler R, Edwards J, Daddow J, Thomas E. Psychosocial factors and chronic pelvic pain:a comparison of women with endometriosis and with unexplained pain. J Psychosom Res. 1996;40(3):305–315. Tamaresis JS, Irwin JC, Goldfien GA, et al.. Molecular Classification of endometriosis and disease stage using high-dimensional genomic data. Endocrinology. 2014;155(12):4986–4999. Johnson MC, Torres M, Alves A, et al.. Augmented cell survival in eutopic endometrium from women with endometriosis:expression of c-myc, TGF-betal and bax genes. Reprod Biol Endocrinol. 2005;3:45. Schenken RS, Johnson JV, Riehl RM. c-myc protooncogene Polypeptide expression in endometriosis. Am J Obstet Gynecol. 1991; 164(4):1031–1036; discussion 1036-1037. Bai MK, Costopoulos JS, Christoforidou BP, Papadimitriou CS. Immunohistochemical detection of the c-myc oncogene produet in normal, hyperplastic and carcinomatous endometrium. Oncol-ogy. 1994;51(4):314–319. Pellegrini C, Gori I, Achtari C, et al.. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin Dl, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis. Fertil Steril. 2012; 98(5):1200–1208. Matsuzaki S, Murakami T, Uehara S, Cards M, Sasano H, Oka-mura K. Expression of estrogen reeeptor alpha and beta in peritoneal and ovarian endometriosis. Fertil Steril. 2001;75(6):1198–1205. Hudelist G, Keckstein J, Czerwenka K, et al.. Estrogen reeeptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril. 2005;84(suppl 2):1249–1256. Smuc T, Pucelj MR, Sinkovec J, Husen B, Thole H, Lanisnik Rizner T. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol. 2007;23(2):105–111. Xue Q, Lin Z, Yin P, et al.. Transcriptional activation of ster-oidogenic factor-1 by hypomethylation of the 5’ CpG island in endometriosis. J Clin Endocrinol Metab. 2007;92(8):3261–3267. Sato S, Ito K, Ozawa N, Yajima A, Sasano H. Expression of c-myc, epidermal growth factor reeeptor and c-erbB-2 in human endometrial Carcinoma and cervical adenocarcinoma. Tohoku J Exp Med. 1991;165(2):137–145. Watson JV, Curling OM, Munn CF, Hudson CN. Oncogene expression in ovarian Cancer:a pilot study of c-myc oncoprotein in serous papillary ovarian Cancer. Gynecol Oncol. 1987;28(2):137–150. Yokoyama Y, Sagara M, Sato S, Saito Y. Value of glutathione S-transferase pi and the oncogene produets c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas. Gynecol Oncol. 1998;68(3):280–287. Borst MP, Baker W, Dixon D, Hatch KD, Shingleton HM, Miller DM. Oncogene alterations in endometrial Carcinoma. Gynecol Oncol. 1990;38(3):364–366. Monk BJ, Chapman JA, Johnson GA, et al.. Correlation of C-myc and HER-2/neu amplification and expression with histopatholo-gic variables in uterine corpus Cancer. Am J Obstet Gynecol. 1994; 171(5):1193–1198. Geisler JP, Geisler HE, Manahan KJ, et al.. Nuclear and cytoplas-mic c-myc staining in endometrial Carcinoma and their relation-ship to survival. Int J Gynecol Cancer. 2004;14(1):133–137. Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial Cancer, endometriosis, uterine fibroids, and breast Cancer. Endocr Rev. 2013;34(1):130–162. Al-Sabbagh M, Lam EW, Brosens JJ. Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol. 2012;358(2):208–215. Bulun SE, Cheng YH, Pavone ME, et al.. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med. 2010;28(1):36–43. Cavallini A, Resta L, Caringella AM, Dinaro E, Lippolis C, Loverro G. Involvement of estrogen receptor-related receptors in human ovarian endometriosis. Fertil Steril. 2011;96(1):102–106. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics. 2006;1(2):106–111. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Vinci, G., Arkwright, S., Audebourg, A. et al. Correlation Between the Clinical Parameters and Tissue Phenotype in Patients Affected by Deep-Infiltrating Endometriosis. Reprod. Sci. 23, 1258–1268 (2016). https://doi.org/10.1177/1933719116638188 Published: Issue date: DOI: https://doi.org/10.1177/1933719116638188